<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03426527</url>
  </required_header>
  <id_info>
    <org_study_id>R/17.09.19</org_study_id>
    <nct_id>NCT03426527</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine for Bilateral Superficial Cervical Plexus Block for Reconstructive Tracheal Surgery</brief_title>
  <official_title>Levobupivacaine Versus Levobupivacaine - Dexmedetomidine for Ultrasound Guided Bilateral Superficial Cervical Plexus Block for Upper Tracheal Resection and Reconstruction Surgery Under General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tracheal resection and reconstruction (TRR) is the treatment of choice for most patients with
      tracheal stenosis or tracheal tumors .The post intubation tracheal stenosis is the common
      indication for (TRR).The immediate postoperative period can be anxiety provoking for some
      reasons such as requirement to maintain a flexed neck, oxygen mask, and surgical pain which
      inadequately treated.

      Bilateral superficial cervical plexus block (BSCPB) is a popular regional anesthesia
      technique for its feasibility and efficacy. The use of regional anesthesia in combination
      with general anesthesia may lighten the level of general anesthesia required , provide
      prolonged postoperative analgesia and reduce the requirements for opioid analgesics

      Dexmedetomidine is a highly selective α2 agonist with high affinity for α2 adrenergic
      receptors and less α1 effects, which is responsible for the hypnotic and analgesic effects.
      Previous trials demonstrated that perineural dexmedetomidine in combination with bupivacaine
      enhanced sensory and motor block ,without neurotoxicity ,in both experimental and clinical
      studies.

      Levobupivacaine, is &quot;S&quot;-enantiomer of bupivacaine, has strongly emerged as a safer
      alternative for regional anesthesia than bupivacaine . Levobupivacaine has been found to be
      equally efficacious as bupivacaine, but with a superior pharmacokinetic profile.

      Clinically, levobupivacaine has been observed to be well tolerated in regional anesthesia
      techniques both after bolus administration and continuous post-operative infusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the intra- and postoperative efficacy of levobupivacaine
      versus levobupivacaine - dexmedetomidine for superficial cervical plexus block for upper
      tracheal resection and reconstruction surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2018</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative postoperative opioid consumption</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Total postoperative opioid consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>Before and for 6 hours after start of anaesthesia</time_frame>
    <description>Perioperative changes in systolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>Before and for 6 hours after start of anaesthesia</time_frame>
    <description>Perioperative changes in diastolic blood pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>Before and for 6 hours after start of anaesthesia</time_frame>
    <description>Perioperative changes in heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peripheral oxygen saturation</measure>
    <time_frame>Before and for 6 hours after start of anaesthesia</time_frame>
    <description>Perioperative changes in peripheral oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End-tidal carbon dioxide tension</measure>
    <time_frame>Before and for 6 hours after start of anaesthesia</time_frame>
    <description>Perioperative changes in end-tidal carbon dioxide tension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time for first analgesic request of analgesia following extubation</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Time to receiving the rescue analgesic following surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores</measure>
    <time_frame>For 24 hours after surgery</time_frame>
    <description>Using visual analogue score (it is 100 mm unmarked line in which 0 = no pain and 100 = worst pain),score &gt;30 mm needs rescue analgesics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortisol serum level</measure>
    <time_frame>before induction of anaesthesia , one hour after the block then one hour after recovery</time_frame>
    <description>Perioperative changes in cortisol level</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tracheal Reconstruction</condition>
  <arm_group>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive bilateral superficial cervical plexus block using levobupivacaine General anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Levobupivacaine-Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive bilateral superficial cervical plexus block using levobupivacaine-dexmedetomidine General anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>Following induction of anaesthesia, patients will receive ultrasound guided bilateral superficial cervical plexus block with levobupivacaine</description>
    <arm_group_label>Levobupivacaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine-Dexmedetomidine</intervention_name>
    <description>Following induction of anaesthesia, patients will receive ultrasound guided bilateral superficial cervical plexus block with levobupivacaine in conjunction with dexmedetomidine</description>
    <arm_group_label>Levobupivacaine-Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>General Anaesthesia</intervention_name>
    <description>Using propofol, fentanyl and atracurium</description>
    <arm_group_label>Levobupivacaine</arm_group_label>
    <arm_group_label>Levobupivacaine-Dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesiologists physical status I or II.

        Exclusion Criteria:

          -  History of allergy to the drugs used

          -  Coagulation disorders

          -  Pregnancy

          -  Postpartum period.

          -  Lactating females

          -  Local sepsis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salwa MS Hayes, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Assistant Professor, MD anesthesia Department, Faculty of Medicine, Mansoura University, Egypt.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hanaa M Elbendary, MD</last_name>
    <phone>00201005781768</phone>
    <email>hanaa_elbendary@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Salwa MS Hayes, MD</last_name>
    <phone>00201002223272</phone>
    <email>salwa.hayes@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mansoura University, Central Hospital, Oto-Rhino-Laryngology anesthesia Unit</name>
      <address>
        <city>Mansourah</city>
        <state>DK</state>
        <zip>050</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2018</study_first_submitted>
  <study_first_submitted_qc>February 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2018</study_first_posted>
  <last_update_submitted>February 7, 2018</last_update_submitted>
  <last_update_submitted_qc>February 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

